Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis

British Journal of Radiology

Volumn 86, Issue 1026, 2013, Pages

  Nilsson, Henrik ^a   Blomqvist, L ^b,c   Douglas, L ^b   Nordell, A ^b   Janczewska, I ^a   Naslund E ^a   Jonas, E ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; PENTETIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; FEMALE; HEPATIC EXTRACTION FRACTION; HUMAN; IMAGE ANALYSIS; INCONGRUENCE SCORE; LIVER CELL; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER PARENCHYMA; LIVER WEIGHT; LUNG BLOOD FLOW; MALE; MEAN TRANSIT TIME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; EVALUATION; FEASIBILITY STUDY; LIVER; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; VASCULARIZATION;

ADULT; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC;

MLCS; MLOWN;

EID: 84879834309     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20120653     Document Type: Article

References (49)

1. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007;204:854 -62. doi: 10.1016/j.jamcollsurg. 2006.12.032; discussion 62-4.
2. Capussotti L, Vigano L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G. Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 2009;96: 88-94. doi: 10.1002/bjs.6429.
3. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-8, discussion 28-9.
4. Sakamoto S, Uemoto S, Uryuhara K, Kim Id, Kiuchi T, Egawa H, et al. Graft size assessment and analysis of donors for living donor liver transplantation using right lobe. Transplantation 2001;71:1407-13. (Pubitemid 32507113)
5. Schroeder T, Radtke A, Kuehl H, Debatin JF, Malagó M, Ruehm SG. Evaluation of living liver donors with an all-inclusive 3D multidetector row CT protocol. Radiology 2006;238:900-10. doi: 10.1148/radiol.2382050133. (Pubitemid 43289920)
6. Morris-Stiff G, Gomez D, Prasad R. Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg 2009;13:374 -85. doi: 10.1007/s11605-008-0564-1.
7. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 2010;12:139-46.
8. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
10. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805. doi: 10.1002/hep.21563. (Pubitemid 46450631)
11. de Graaf W, van Lienden KP, van Gulik TM, Bennink RJ. (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 2010;51:229 -36. doi: 10.2967/jnumed.109.069724.
12. Imaeda T, Kanematsu M, Asada S, Seki M, Doi H, Saji S. Utility of Tc-99m GSA SPECT imaging in estimation of functional volume of liver segments in health and liver diseases. Clin Nucl Med 1995;20:322-8.
13. Matsuzaki S, Onda M, Tajiri T, Kim DY. Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve. Hepatology 1997;25:828-32. doi: 10.1002/hep.510250407. (Pubitemid 27157121)
14. Jonas E, Näslund E, Freedman J, Befrits R, Blomqvist L, Siosteen AK, et al. Measurement of parenchymal function and bile duct flow in primary sclerosing cholangitis using dynamic 99mTc-HIDA SPECT. J Gastroenterol Hepatol 2006;21:674-81. doi: 10.1111/j.1440-1746.2005.04084.x.
15. Nassif A, Jia J, Keiser M, Oswald S, Modess C, Nagel S, et al. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Radiology 2012;264:741-50. doi: 10.1148/radiol.12112061.
16. Leonhardt M, Keiser M, Oswald S, Kühn J, Jia J, Grube M, et al. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos 2010;38:1024-8. doi: 10.1124/dmd.110.032862.
17. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009;44:793-8. doi: 10.1007/s00535-009-0056-4.
18. Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acidenhanced MR Imaging-correlation with molecular transporters and histopathologic features. Radiology 2010;256:817-26. doi: 10.1148/radiol.10092214.
19. Schuhmann-Giampieri G. Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. Invest Radiol 1993;28:753-61. (Pubitemid 24081774)
20. de Graaf W, Hausler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, et al. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol 2011;54:738-45. doi: 10.1016/j.jhep.2010.07. 047.
21. Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-92.
22. Kim T, Murakami T, Hasuike Y, Gotoh M, Kato N, Takahashi M, et al. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 1997;7:683-8. (Pubitemid 28365618)
23. Murakami T, Kim T, Gotoh M, Hasuike Y, Kato N, Miyazawa T, et al. Experimental hepatic dysfunction: evaluation by MR imaging with Gd-EOB-DTPA. Acad Radiol 1998;5:S80-2.
24. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, et al. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 2004;5:231-9.
25. Schmitz SA, Mühler A, Wagner S, Wolf KJ. Functional hepatobiliary imaging with gadolinium-EOBDTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Invest Radiol 1996; 31:154-60.
26. Yamada A, Hara T, Li F, Fujinaga Y, Ueda K, Kadoya M, et al. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology 2011;260:727-33. doi: 10.1148/radiol.11100586.
27. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging. 2009;30:1042-6.
28. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008;18:1577-86.
29. Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPAenhanced liver MRI. HPB (Oxford) 2010;12:567 -76. doi: 10.1111/j.1477-2574.2010.00223.x.
30. Saito K, Ledsam J, Sourbron S, Otaka J, Araki Y, Akata S, et al. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging 2012; in press. E-pub ahead of print october 2012. doi: 10.1002/jmri.23907.
31. Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L. Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocytespecific contrast-enhanced MRI. J Magn Reson Imaging 2009;29:1323-31. doi: 10.1002/jmri.21801.
32. Desmet VJ, GerberM, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20. (Pubitemid 24166476)
33. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70. doi: 10.1053/jhep.2001.22172. (Pubitemid 32119037)
34. Strasberg SM. Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 1997;184:413-34. (Pubitemid 27172831)
35. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005;12:351-5. doi: 10.1007/s00534-005-0999-7. (Pubitemid 41662443)
36. Dodds WJ, Erickson SJ, Taylor AJ, Lawson TL, Stewart ET. Caudate lobe of the liver: anatomy, embryology, and pathology. AJR Am J Roentgenol 1990;154:87 -93.
37. Brown PH, Juni JE, Lieberman DA, Krishnamurthy GT. Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. J Nucl Med 1988;29:623-30.
38. Blomquist L, Wang Y, Kimiaei S, Jacobsson H. Change in size, shape and radiocolloid uptake of the alcoholic liver during alcohol withdrawal, as demonstrated by single photon emission computed tomography. J Hepatol 1994;21:417-23. (Pubitemid 24308767)
39. Shreiner DP, Barlai-Kovach M. Diagnosis of alcoholic cirrhosis with the right-to-left hepatic lobe ratio: concise communication. J Nucl Med 1981;22:116-20.
40. Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 1980;135:273-83. (Pubitemid 10105887)
41. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr 1986;10:47-50. (Pubitemid 16149198)
42. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-14. doi: 10.1148/radiol.2292021128. (Pubitemid 37310826)
43. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11:860-8. doi: 10.1007/s11605-007-0149-4.
44. Pessaux P, Chenard MP, Bachellier P, Jaeck D. Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg 2010;147:e193-201. doi: 10.1016/j.jviscsurg.2010.06.004.
45. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007;46:582-9. doi: 10.1002/hep.21768. (Pubitemid 47344794)
46. Arun J, Jhala N, Lazenby AJ, Clements R, Abrams GA. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. Obes Surg 2007;17: 155-61. doi: 10.1007/s11695-007- 9041-2. (Pubitemid 47091575)
47. Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Clin Gastroenterol Hepatol 2007;5: 1329-32. doi: 10.1016/j.cgh.2007.06.005. (Pubitemid 350019053)
48. Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874 - 80. doi: 10.1002/hep.21346.
49. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-906. (Pubitemid 40824701)